American Heart Journal

1

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

Adrian F. Hernandez, Christopher M. O'Connor, Randall C. Starling, Craig J. Reist, Paul W. Armstrong, Kenneth Dickstein, Todd J. Lorenz, W. Brian Gibler, Vic Hasselblad, Michel Komajda, Barry Massie,

Journal:

Year:

2009

Language:

english

File:

PDF, 166 KB

english, 2009

2

Current role of emboli protection devices in percutaneous coronary and vascular interventions

Marco Roffi, Debabrata Mukherjee

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 339 KB

english, 2009

3

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

Herbert D. Aronow, Steven R. Steinhubl, Danielle M. Brennan, Peter B. Berger, Eric J. Topol

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 181 KB

english, 2009

4

Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology

Marcelo Nigri, Clerio F. Azevedo, Carlos Eduardo Rochitte, Vladimir Schraibman, Flavio Tarasoutchi, Pablo M. Pommerantzeff, Carlos Manuel Brandão, Roney O. Sampaio, José R. Parga, Luiz F. Ávila, Guilh

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 653 KB

english, 2009

5

Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome

Gilles Lemesle, Cédric Delhaye, Arnaud Sudre, Damien Broucqsault, Guillaume Rosey, Christophe Bauters, Jean-Marc Lablanche

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 226 KB

english, 2009

6

Differences in initial severity of illness between black and white emergency department patients hospitalized with heart failure

Thomas E. Auble, Margaret Hsieh, Donald M. Yealy

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 130 KB

english, 2009

7

Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest

Zacharias Alexandros Anyfantakis, Gabriel Baron, Pierre Aubry, Dominique Himbert, Laurent J. Feldman, Jean-Michel Juliard, Agnès Ricard-Hibon, Alexis Burnod, Dennis V. Cokkinos, Philippe Gabriel Steg

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 204 KB

english, 2009

8

Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction

François Schiele, Nicolas Meneveau, Romain Chopard, Vincent Descotes-Genon, Joanna Oettinger, Marie France Seronde, Florent Briand, Yvette Bernard, Fiona Ecarnot, Jean-Pierre Bassand

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 370 KB

english, 2009

9

Ultrafiltration for heart failure: How fast should we move?

Amir Kazory, A. Ahsan Ejaz, Edward A. Ross

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 81 KB

english, 2009

10

Health status as a risk factor in cardiovascular disease: A systematic review of current evidence

Paula M.C. Mommersteeg, Johan Denollet, John A. Spertus, Susanne S. Pedersen

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 319 KB

english, 2009

11

A multifaceted intervention to improve blood pressure control: The Guideline Adherence for Heart Health (GLAD) study

Denise E. Bonds, Patricia E. Hogan, Alain G. Bertoni, Haiying Chen, C. Randall Clinch, Ann E. Hiott, Erica L. Rosenberger, David C. Goff

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 266 KB

english, 2009

12

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel Bloomfield, Gary L. Carlson, Aditi Sapre, Diane Tribble, James M. McKenney, Thomas W. Littlejohn III, Christine McCrary Sisk, Yale Mitchel, Richard C. Pasternak

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 450 KB

english, 2009

13

Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study

Eloi Marijon, Ludovic Trinquart, Akli Otmani, Xavier Waintraub, Salem Kacet, Jacques Clémenty, Gilles Chatellier, Jean-Yves Le Heuzey

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 256 KB

english, 2009

14

Protease-activated receptors in cardiovascular health and diseases

Rahman Shah

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 484 KB

english, 2009

15

Defining an evidence-based cutpoint for medication adherence in heart failure

Jia-Rong Wu, Debra K. Moser, Marla J. De Jong, Mary Kay Rayens, Misook L. Chung, Barbara Riegel, Terry A. Lennie

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 276 KB

english, 2009

16

Standardizing care for acute decompensated heart failure in a large megatrial: The approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)

Justin A. Ezekowitz, Adrian F. Hernandez, Randall C. Starling, Clyde W. Yancy, Barry Massie, James A. Hill, Henry Krum, Rafael Diaz, Piotr Ponikowski, Marco Metra, Jonathon G. Howlett, Daniel Gennevoi

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 163 KB

english, 2009

17

Percutaneous transcatheter aortic valve implantation: Evolution of the technology

Paul T.L. Chiam, Carlos E. Ruiz

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 414 KB

english, 2009

18

Evaluation of left ventricular short- and long-axis function in severe mitral regurgitation using 2-dimensional strain echocardiography

Min-Seok Kim, Yong-Jin Kim, Hyung-Kwan Kim, Joo-Yong Han, Hong-Gu Chun, Hee-Chan Kim, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 308 KB

english, 2009

19

Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)

Kim A. Eagle

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 364 KB

english, 2009

20

Daily walking performance as an independent predictor of advanced heart failure: Prediction of exercise capacity in chronic heart failure

Melissa Jehn, Arno Schmidt-Trucksäss, Tibor Schuster, Michael Weis, Henner Hanssen, Martin Halle, Friedrich Koehler

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 302 KB

english, 2009

21

Incremental value of renal function in risk prediction with the Seattle Heart Failure Model

Grigorios Giamouzis, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Syed A. Agha, Mohammad A. Rashad, Sonjoy R. Laskar, Andrew L. Smith, Javed Butler

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 276 KB

english, 2009

22

S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies

Majken K. Jensen, Eric B. Rimm, Daniel Rader, Erik B. Schmidt, Thorkild I.A. Sørensen, Ulla Vogel, Kim Overvad, Kenneth J. Mukamal

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 234 KB

english, 2009

23

Current concepts in the pathogenesis of atrial fibrillation

Antonios Kourliouros, Irina Savelieva, Anatoli Kiotsekoglou, Marjan Jahangiri, John Camm

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 244 KB

english, 2009

24

Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations

Thomas J. Povsic, Katherine L. Zavodni, Enrikas Vainorius, Jennifer F. Kherani, Pascal J. Goldschmidt-Clermont, Eric D. Peterson

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 1.01 MB

english, 2009

25

Risk factors and stroke risk stratification for atrial fibrillation

Oscar M.P. Jolobe

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 53 KB

english, 2009

26

Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”

Gregory Y.H. Lip

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 58 KB

english, 2009

27

Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation

Jacob I. Haft

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 60 KB

english, 2009

28

Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation

Gregory Y.H. Lip

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

29

Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: Results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study

Matteo Cesari, Stephen B. Kritchevsky, Hal H. Atkinson, Brenda W. Penninx, Mauro Di Bari, Russell P. Tracy, Marco Pahor

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 198 KB

english, 2009

30

On coronary analyses

Arthur David Tsakok

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 64 KB

english, 2009

31

Light-dark patterns of soluble CD40 ligand: Clinical implications

Alberto Dominguez-Rodríguez, Pedro Abreu-Gonzalez

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 74 KB

english, 2009

32

Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo

Aloke V. Finn, Jae S. Oh, Michael Hendricks, Maureen Daher, Enrico Cagliero, Raphael M. Byrne, Jeffrey Nadelson, Johanna Crimins, Adnan Kastrati, Albert Schömig, Olga Bruskina, Igor Palacios, Michael

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 297 KB

english, 2009

33

Editorial Board

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 37 KB

english, 2009

35

Information for Authors

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 72 KB

english, 2009

36

Information for Readers

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 34 KB

english, 2009

Volume 157; Issue 2

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

Current role of emboli protection devices in percutaneous coronary and vascular interventions

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology

Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome

Differences in initial severity of illness between black and white emergency department patients hospitalized with heart failure

Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest

Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction

Ultrafiltration for heart failure: How fast should we move?

Health status as a risk factor in cardiovascular disease: A systematic review of current evidence

A multifaceted intervention to improve blood pressure control: The Guideline Adherence for Heart Health (GLAD) study

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study

Protease-activated receptors in cardiovascular health and diseases

Defining an evidence-based cutpoint for medication adherence in heart failure

Standardizing care for acute decompensated heart failure in a large megatrial: The approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)

Percutaneous transcatheter aortic valve implantation: Evolution of the technology

Evaluation of left ventricular short- and long-axis function in severe mitral regurgitation using 2-dimensional strain echocardiography

Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)

Daily walking performance as an independent predictor of advanced heart failure: Prediction of exercise capacity in chronic heart failure

Incremental value of renal function in risk prediction with the Seattle Heart Failure Model

S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies

Current concepts in the pathogenesis of atrial fibrillation

Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations

Risk factors and stroke risk stratification for atrial fibrillation

Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”

Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation

Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation

Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: Results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study

On coronary analyses

Light-dark patterns of soluble CD40 ligand: Clinical implications

Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo

Table of Contents

Editorial Board

Information for Authors

Information for Readers